Browsing by Subject "A61P 5/14"
Now showing items 1-1 of 1
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.